Conference call with management to be held on February 9 at 2 pm hosted by William Blair.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics today
- Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI
- Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path
- Cathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares
- Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating